Intestinal metaplasia: A premalignant lesion involved in gastric carcinogenesis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 2, 2009, Pages 193-201

  Busuttil, Rita A ^b   Boussioutas, Alex ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Caudal type Homeobox gene; Gastric Cancer; Gene expression; Intestinal Metaplasia; Runt related transcription factor; Sonic hedgehog

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN P53; SONIC HEDGEHOG PROTEIN; TELOMERASE; TRANSCRIPTION FACTOR CDX1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR SOX2; TREFOIL PEPTIDE; VILLIN;

CANCER GROWTH; CANCER RISK; CARCINOGENESIS; EARLY DIAGNOSIS; ENZYME ACTIVATION; GENE EXPRESSION; HELICOBACTER INFECTION; HETEROZYGOSITY LOSS; HUMAN; INTESTINE METAPLASIA; MICROSATELLITE INSTABILITY; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER;

EID: 58849119019     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05774.x     Document Type: Review

References (82)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005 55 : 74 108.
2. Parkin DM. International variation. Oncogene 2004 23 : 6329 40.
3. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the 'different disease' hypothesis. Cancer 2000 88 : 921 32.
4. Yamamoto H, Kita H. Endoscopic therapy of early gastric cancer. Best. Pract. Res. Clin. Gastroenterol. 2005 19 : 909 26.
5. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta. Pathol. Microbiol. Scand. 1965 64 : 31 49.
6. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988 48 : 3554 60.
7. Boussioutas A, Li H, Liu J et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res. 2003 63 : 2569 77.
8. Rubio CA, Hirota T, Itabashi M et al. Extended intestinal metaplasia. A survey of 1392 gastrectomies from dwellers of the Pacific basin. Anticancer Res. 2004 24 : 3185 92.
9. Jass JR, Filipe MI. A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology 1979 3 : 191 9.
10. You WC, Li JY, Blot WJ et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int. J. Cancer 1999 83 : 615 19.
11. Correa P. Chemoprevention of gastric cancer: has the time come? J. Clin. Oncol. 2003 21 (Suppl. 23 s270 1.
12. Filipe MI, Potet F, Bogomoletz WV et al. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut 1985 26 : 1319 26.
13. Kang KP, Lee HS, Kim N et al. Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea. J. Gastroenterol. Hepatol. 2008.
14. Conchillo JM, Houben G, de Bruine A, Stockbrugger R. Is type III intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma? Eur. J. Cancer Prev. 2001 10 : 307 12.
15. Leung WK, Lin SR, Ching JY et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004 53 : 1244 9.
16. Jaiswal M, LaRusso NF, Gores GJ. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 2001 281 : G626 34.
17. De Luca A, Iaquinto G. Helicobacter pylori and gastric diseases: a dangerous association. Cancer Lett. 2004 213 : 1 10.
18. Kim N, Park RY, Cho SI et al. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. J. Clin. Gastroenterol. 2008 42 : 448 54.
19. Peek RM Jr., Blaser, MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2002 2 : 28 37.
20. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J. Gastroenterol. 2006 12 : 354 62.
21. Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig. Liver Dis. 2008 40 : 619 26.
22. Correa P, Fontham ET, Bravo JC et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J. Natl. Cancer Inst. 2000 92 : 1881 8.
23. Uemura N, Mukai T, Okamoto S et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol. Biomarkers Prev. 1997 6 : 639 42.
24. Morales TG, Sampliner RE, Camargo E, Marquis S, Garewal HS, Fennerty MB. Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication. J. Clin. Gastroenterol. 2001 32 : 400 4.
25. van der Hulst RW, van der Ende A, Dekker FW et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997 113 : 25 30.
26. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007 12 (Suppl. 2 32 8.
27. El-Zimaity HM, Ramchatesingh J, Saeed MA, Graham DY. Gastric intestinal metaplasia: subtypes and natural history. J. Clin. Pathol. 2001 54 : 679 83.
28. Leung WK, Kim JJ, Kim JG, Graham DY, Sepulveda AR. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am. J. Pathol. 2000 156 : 537 43.
29. Hamamoto T, Yokozaki H, Semba S et al. Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers. J. Clin. Pathol. 1997 50 : 841 6.
30. Kameshima H, Yagihashi A, Yajima T et al. Helicobacter pylori infection: augmentation of telomerase activity in cancer and noncancerous tissues. World J. Surg. 2000 24 : 1243 9.
31. Maruyama Y, Hanai H, Fujita M, Kaneko E. Telomere length and telomerase activity in carcinogenesis of the stomach. Jpn. J. Clin. Oncol. 1997 27 : 216 20.
32. Liu Q, Teh M, Ito K, Shah N, Ito Y, Yeoh KG. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer. Mod. Pathol. 2007 20 : 1286 97.
33. Kim BW, Kim KM, Lee BI et al. Expression of trefoil peptides in the subtypes of intestinal metaplasia. Peptides 2004 25 : 779 83.
34. Tsukamoto T, Mizoshita T, Mihara M et al. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology 2005 46 : 649 58.
35. Leys CM, Nomura S, Rudzinski E et al. Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma. Hum. Pathol. 2006 37 : 1162 8.
36. Almeida R, Almeida J, Shoshkes M et al. OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells. J. Pathol. 2005 207 : 396 401.
37. Osaki M, Moriyama M, Adachi K et al. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma. Eur. J. Clin. Invest. 2004 34 : 605 12.
38. Shiotani A, Iishi H, Uedo N et al. Evidence that loss of sonic hedgehog is an indicator of Helicobater pylori-induced atrophic gastritis progressing to gastric cancer. Am. J. Gastroenterol. 2005 100 : 581 7.
39. van den Brink GR, Hardwick JC, Tytgat GN et al. Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology 2001 121 : 317 28.
40. Suzuki K, Kashimura H, Ohkawa J et al. Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions. J. Gastroenterol. Hepatol. 2000 15 : 744 51.
41. Lan J, Xiong YY, Lin YX et al. Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation. World J. Gastroenterol. 2003 9 : 54 8.
42. Silberg DG, Swain GP, Suh ER, Traber PG. Cdx1 and cdx2 expression during intestinal development. Gastroenterology 2000 119 : 961 71.
43. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat. Rev. Cancer 2003 3 : 592 600.
44. Eda A, Osawa H, Yanaka I et al. Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J. Gastroenterol. 2002 37 : 94 100.
45. Yuasa Y, Nagasaki H, Akiyama Y et al. Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients. Carcinogenesis 2005 26 : 193 200.
46. Lefebvre O, Chenard MP, Masson R et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996 274 : 259 62.
47. Wong WM, Poulsom R, Wright NA. Trefoil peptides. Gut 1999 44 : 890 5.
48. Shimada T, Koike T, Yamagata M, Yoneda M, Hiraishi H. Regulation of TFF3 expression by homeodomain protein CDX2. Regul. Pept. 2007 140 : 81 7.
49. MacLennan AJ, Orringer MB, Beer DG. Identification of intestinal-type Barrett's metaplasia by using the intestine-specific protein villin and esophageal brush cytology. Mol. Carcinog. 1999 24 : 137 43.
50. Rieder G, Tessier AJ, Qiao XT, Madison B, Gumucio DL, Merchant JL. Helicobacter-induced intestinal metaplasia in the stomach correlates with Elk-1 and serum response factor induction of villin. J. Biol. Chem. 2005 280 : 4906 12.
51. Qiao XT, Ziel JW, McKimpson W et al. Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology 2007 133 : 1989 98.
52. Offield MF, Jetton TL, Labosky PA et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996 122 : 983 95.
53. Larsson LI, Madsen OD, Serup P, Jonsson J, Edlund H. Pancreatic-duodenal homeobox 1 -role in gastric endocrine patterning. Mech. Dev. 1996 60 : 175 84.
54. Li QL, Ito K, Sakakura C et al. Causal relationship between the loss of RUNX3 expression and gastric. cancer. Cell 2002 109 : 113 24.
55. Kitajima Y, Ohtaka K, Mitsuno M et al. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol. Rep. 2008 19 : 197 202.
56. Rodier F, Campisi J, Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Res. 2007 35 : 7475 84.
57. Yokozaki H, Kuniyasu H, Kitadai Y et al. p53 point mutations in primary human gastric carcinomas. J. Cancer Res. Clin. Oncol. 1992 119 : 67 70.
58. Ochiai A, Yamauchi Y, Hirohashi S. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int. J. Cancer 1996 69 : 28 33.
59. Anagnostopoulos GK, Stefanou D, Arkoumani E et al. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions. J. Gastroenterol. Hepatol. 2008 23 : 626 31.
60. Lee CJ, Dosch J, Simeone DM. Pancreatic cancer stem cells. J. Clin. Oncol. 2008 26 : 2806 12.
61. Buettner M, Dimmler A, Magener A et al. Gastric PDX-1 expression in pancreatic metaplasia and endocrine cell hyperplasia in atrophic corpus gastritis. Mod. Pathol. 2004 17 : 56 61.
62. van den Brink GR, Hardwick JC, Nielsen C et al. Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract. Gut 2002 51 : 628 33.
63. Subramanian V, Meyer BI, Gruss P. Disruption of the murine homeobox gene Cdx1 affects axial skeletal identities by altering the mesodermal expression domains of Hox genes. Cell 1995 83 : 641 53.
64. Chawengsaksophak K, James R, Hammond VE, Kontgen F, Beck F. Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 1997 386 : 84 7.
65. Mutoh H, Sakurai S, Satoh K et al. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut 2004 53 : 1416 23.
66. Silberg DG, Sullivan J, Kang E et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2002 122 : 689 96.
67. Mutoh H, Sakurai S, Satoh K et al. Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res. 2004 64 : 7740 7.
68. Fox JG, Li X, Cahill RJ et al. Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 1996 110 : 155 66.
69. Hu GY, Yu BP, Dong WG et al. Expression of TFF2 and Helicobacter pylori infection in carcinogenesis of gastric mucosa. World J. Gastroenterol. 2003 9 : 910 14.
70. Nowell PC. The clonal evolution of tumor cell populations. Science 1976 194 : 23 8.
71. McDonald SA, Greaves LC, Gutierrez-Gonzalez L et al. Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells. Gastroenterology 2008 134 : 500 10.
72. Houghton J, Stoicov C, Nomura S et al. Gastric cancer originating from bone marrow-derived cells. Science 2004 306 : 1568 71.
73. Tebbutt NC, Giraud AS, Inglese M et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 2002 8 : 1089 97.
74. Judd LM, Alderman BM, Howlett M et al. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 2004 126 : 196 207.
75. Maeda S, Mentis AF. Pathogenesis of Helicobacter pylori infection. Helicobacter 2007 12 (Suppl. 1 10 14.
76. Yeoh KG. How do we improve outcomes for gastric cancer? J. Gastroenterol. Hepatol. 2007 22 : 970 2.
77. Correa P. Is gastric cancer preventable? Gut 2004 53 : 1217 19.
78. Axon A. Symptoms and diagnosis of gastric cancer at early curable stage. Best. Pract. Res. Clin. Gastroenterol. 2006 20 : 697 708.
79. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991 32 : 1110 13.
80. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant lesions. Gut 2002 50 : 378 81.
81. Wong BC, Lam SK, Wong WM et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomoized controlled trial. JAMA 2004 291 : 187 94.
82. de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007 12 : 1 15.